PeptX supplies Eloralintide (LY3841136), Eli Lilly's selective long-acting amylin receptor analogue currently in the ENLIGHTEN Phase 3 programme, to UK research laboratories and group-buy collectives. Pre-order pricing, 99%+ HPLC verified purity, tracked UK domestic dispatch on release.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.